Immunodiagnostic Systems Hldgs PLC Results of AGM (9297T)
July 23 2020 - 9:57AM
UK Regulatory
TIDMIDH
RNS Number : 9297T
Immunodiagnostic Systems Hldgs PLC
23 July 2020
Results of AGM
Immunodiagnosti c Systems Holdings PLC
23 July 2020
Immunodiagnosti c Systems Holdings plc
Results of AGM
Immunodiagnostic Systems Holdings PLC ("the Company"), a
specialist producer of manual and automated diagnostic testing kits
and instruments for the clinical and research markets, announces
the results of its Annual General Meeting (the "Meeting") that was
held at 2pm today.
Trading Update
The Chairman of the Meeting provided a business update and a
copy of the statement has been made available on the Company's
website.
Voting Results
All resolutions put to the Meeting were decided on a show of
hands and all were duly passed.
For information, details of the proxy voting are shown
below:
Resolution Votes For Votes Votes Votes
For Against Withheld
(as % of (as % of
votes votes
cast) cast)
1. To receive the
accounts
for the year ended 31
March 2020 together
with
the report of the
Directors
and of the Auditor
thereon. 15,238,341 100.00% 0.00% 0
------------------------ ---------------------- ---------------------- ----------------------
2. To declare a final
dividend for the year
ended 31 March 2020. 15,238,341 100.00% 0.00% 0
------------------------ ---------------------- ---------------------- ----------------------
3. To re-appoint
Pricewaterhouse-Coopers
LLP as Auditor of the
Company. 15,238,341 100.00% 0.00% 0
------------------------ ---------------------- ---------------------- ----------------------
4. To authorise the
Directors
of the Company to
determine
the remuneration of the
Auditor of the Company. 15,238,341 100.00% 0.00% 0
------------------------ ---------------------- ---------------------- ----------------------
5. To approve the
Directors'
Remuneration Report for
the financial year
ended
31 March 2020. 14,436,907 94.75% 5.25% 814
------------------------ ---------------------- ---------------------- ----------------------
6. To authorise the
Directors
to allot relevant
securities. 14,437,577 94.75% 5.25% 764
------------------------ ---------------------- ---------------------- ----------------------
7. To authorise the
disapplication
of pre-emption rights
in accordance with
section
570 of the Companies
Act 2006. 14,437,577 94.75% 5.25% 764
------------------------ ---------------------- ---------------------- ----------------------
8. To authorise the
Directors
to make market
purchases. 15,238,341 100.00% 0.00% 0
------------------------ ---------------------- ---------------------- ----------------------
The full text of each of the resolutions is set out in the
notice of Annual General Meeting, copies of which are available on
the IDS website (www.idsplc.com).
For further information:
Immunodiagnosti c Systems Holdings plc Tel : +44 (0)191
5190660
Paul Martin, Group Finance Director
Pee l Hunt LLP Tel : +44 (0)207 418 8900
James Steel
Oliver Jackson
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGFLFEVDSIVFII
(END) Dow Jones Newswires
July 23, 2020 09:57 ET (13:57 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Jul 2023 to Jul 2024
